Compound E, chemically designated as 209986-17-4 (CAS), represents a significant study within the field of Alzheimer's disease research. This γ-secretase inhibitor was initially developed as a promising therapeutic https://mariyahttus350386.pointblog.net/γ-secretase-suppressor-compound-e-209986-17-4-91834622